Overview
and Scope
ADME toxicology testing is a set of studies conducted to assess the potential
toxicity of a substance or drug candidate based on its absorption,
distribution, metabolism, and excretion (ADME) properties. These tests are used
in drug development to ensure the well-being of individuals exposed to
substances.
Sizing and Forecast
The adme toxicology testing market size has grown rapidly in recent years. It
will grow from $9.3 billion in 2023 to $10.34 billion in 2024 at a compound
annual growth rate (CAGR) of 11.2%.
The growth in the historic period
can be attributed to stringent regulatory requirements, rising drug development
activities, growing concerns about drug safety, advancements in in vitro
testing methods, increased outsourcing of toxicology studies..
The adme toxicology testing market size is expected to see rapid growth in the
next few years. It will grow to $15.77 billion in 2028 at a compound annual
growth rate (CAGR) of 11.1%. The growth
in the forecast period can be attributed to rapid expansion of
biopharmaceuticals, growing emphasis on personalized medicine, emergence of
advanced therapies, enhanced predictive toxicology models, global increase in
chemical safety testing.. Major trends in the forecast period include expansion
of biomarker applications, integration of multi-omics data, regulatory emphasis
on in vitro testing, collaborations and partnerships, continuous advancements
in technology..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report
Segmentation & Regional Insights
The adme toxicology testing market covered in this report is segmented –
1) By Product Type: Instruments, Software Solutions, Assays Systems,
Reagents, Other Products
2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-vivo
3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS
Technology, Other Technologies
4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity,
Neurotoxicity, Other Applications
5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry,
Animal Industry, Food Industry, Other End Users
North America was the largest region in
the ADME toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region
in the forecast period. The regions covered in the adme toxicology testing
market report are Asia-Pacific, Western Europe, Eastern Europe, North America,
South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the
report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp
Major Driver Impacting Market Growth
The rising demand for novel drugs is expected to propel the growth of the ADME
toxicology testing market going forward. Novel drugs are pharmaceutical
substances that have not been previously approved or marketed for therapeutic
use. ADME toxicity testing is a major step in drug development to ensure that
the novel drug is safe and doesn’t produce any harmful toxins in the body. For
instance, according to the US Food and Drug Administration, a US-based health
regulatory authority approved 53 novel drugs in 2022, compared to 50 drugs in
the previous year. Therefore, the rising demand for novel drugs is driving the
growth of the ADME toxicology testing market.
Key Industry Players
Major companies operating in the adme toxicology testing market report are
AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH,
Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins
Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE,
Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter
Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega
Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus
Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative
Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited,
Admecell Inc., Molecular Discovery Ltd.
The adme toxicology testing market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional
And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future
Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment